CN104825570A - 一种抑制幽门螺杆菌的组合物及其用途 - Google Patents
一种抑制幽门螺杆菌的组合物及其用途 Download PDFInfo
- Publication number
- CN104825570A CN104825570A CN201510257543.6A CN201510257543A CN104825570A CN 104825570 A CN104825570 A CN 104825570A CN 201510257543 A CN201510257543 A CN 201510257543A CN 104825570 A CN104825570 A CN 104825570A
- Authority
- CN
- China
- Prior art keywords
- extract
- hericium erinaceus
- composition
- rhizoma coptidis
- gastritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 241000590002 Helicobacter pylori Species 0.000 title claims abstract description 13
- 229940037467 helicobacter pylori Drugs 0.000 title claims abstract description 13
- 230000002401 inhibitory effect Effects 0.000 title 1
- 240000000588 Hericium erinaceus Species 0.000 claims abstract description 32
- 235000007328 Hericium erinaceus Nutrition 0.000 claims abstract description 32
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 208000007882 Gastritis Diseases 0.000 claims abstract description 7
- 201000010099 disease Diseases 0.000 claims abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 6
- 208000005718 Stomach Neoplasms Diseases 0.000 claims abstract description 5
- 206010017758 gastric cancer Diseases 0.000 claims abstract description 5
- 201000011549 stomach cancer Diseases 0.000 claims abstract description 5
- 208000016644 chronic atrophic gastritis Diseases 0.000 claims abstract description 4
- 230000001684 chronic effect Effects 0.000 claims abstract description 4
- 206010009900 Colitis ulcerative Diseases 0.000 claims abstract description 3
- 208000007107 Stomach Ulcer Diseases 0.000 claims abstract description 3
- 201000006704 Ulcerative Colitis Diseases 0.000 claims abstract description 3
- 208000010643 digestive system disease Diseases 0.000 claims abstract description 3
- 208000000718 duodenal ulcer Diseases 0.000 claims abstract description 3
- 201000005917 gastric ulcer Diseases 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 claims description 14
- 244000063299 Bacillus subtilis Species 0.000 claims description 6
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 6
- 241000194033 Enterococcus Species 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 5
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 4
- 244000199866 Lactobacillus casei Species 0.000 claims description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 4
- 229940017800 lactobacillus casei Drugs 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 241000589989 Helicobacter Species 0.000 claims description 3
- 201000011510 cancer Diseases 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- 239000006041 probiotic Substances 0.000 claims description 3
- 230000000529 probiotic effect Effects 0.000 claims description 3
- 235000018291 probiotics Nutrition 0.000 claims description 3
- 210000001187 pylorus Anatomy 0.000 claims description 3
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 2
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 2
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 2
- 241001505096 Rhamnus davurica Species 0.000 claims description 2
- 208000025865 Ulcer Diseases 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 2
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 2
- 231100000397 ulcer Toxicity 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 239000002131 composite material Substances 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 208000008469 Peptic Ulcer Diseases 0.000 abstract description 2
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 241001145009 Sophora alopecuroides Species 0.000 abstract 1
- 230000036210 malignancy Effects 0.000 abstract 1
- 244000309464 bull Species 0.000 description 16
- 239000008194 pharmaceutical composition Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- QBKSWRVVCFFDOT-UHFFFAOYSA-N gossypol Chemical compound CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(C=3C(O)=C4C(C=O)=C(O)C(O)=C(C4=CC=3C)C(C)C)=C(C)C=C21 QBKSWRVVCFFDOT-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- -1 with parts by weight Substances 0.000 description 3
- QHOPXUFELLHKAS-UHFFFAOYSA-N Thespesin Natural products CC(C)c1c(O)c(O)c2C(O)Oc3c(c(C)cc1c23)-c1c2OC(O)c3c(O)c(O)c(C(C)C)c(cc1C)c23 QHOPXUFELLHKAS-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229930000755 gossypol Natural products 0.000 description 2
- 229950005277 gossypol Drugs 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
药物 | 抑菌圈(mm) |
猴头菌:苦豆子:黄连提取物(15:15:6) | 28 |
猴头菌:苦豆子:黄连提取物(18:12:8) | 35 |
猴头菌:苦豆子:黄连提取物(20:10:10) | 24 |
猴头菌:猴头菌:猴头菌(15:15:15) | 21 |
猴头菌:猴头菌:猴头菌(20:20:20) | 23 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510257543.6A CN104825570B (zh) | 2015-05-20 | 2015-05-20 | 一种抑制幽门螺杆菌的组合物及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510257543.6A CN104825570B (zh) | 2015-05-20 | 2015-05-20 | 一种抑制幽门螺杆菌的组合物及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104825570A true CN104825570A (zh) | 2015-08-12 |
CN104825570B CN104825570B (zh) | 2019-07-05 |
Family
ID=53804021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510257543.6A Active CN104825570B (zh) | 2015-05-20 | 2015-05-20 | 一种抑制幽门螺杆菌的组合物及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104825570B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106309758A (zh) * | 2016-09-30 | 2017-01-11 | 湖南新汇制药股份有限公司 | 一种抗胃肠癌的药物组合物 |
CN107898999A (zh) * | 2017-11-27 | 2018-04-13 | 广东省微生物研究所(广东省微生物分析检测中心) | 一种含有猴头菌蛋白的微生物制剂及其制备方法和用途 |
CN108159085A (zh) * | 2018-01-22 | 2018-06-15 | 梁勇 | 一种益生菌溃疡贴 |
CN110591945A (zh) * | 2019-09-06 | 2019-12-20 | 吉林大学 | 一株用于预防溃疡性结肠炎的优良罗伊氏乳杆菌 |
CN112451540A (zh) * | 2020-11-25 | 2021-03-09 | 华熙生物科技股份有限公司 | 抗幽门螺杆菌消化道内感染活性的透明质酸 |
CN114480231A (zh) * | 2022-04-18 | 2022-05-13 | 南京益瑞兰生物科技有限公司 | 一种抗幽门螺杆菌感染的罗伊氏乳杆菌及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102731365A (zh) * | 2011-04-06 | 2012-10-17 | 中国科学院上海生命科学研究院 | 猴头菌抑制幽门螺杆菌的生物小分子及其在治疗消化道疾病中的应用 |
-
2015
- 2015-05-20 CN CN201510257543.6A patent/CN104825570B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102731365A (zh) * | 2011-04-06 | 2012-10-17 | 中国科学院上海生命科学研究院 | 猴头菌抑制幽门螺杆菌的生物小分子及其在治疗消化道疾病中的应用 |
Non-Patent Citations (3)
Title |
---|
XIAODONG SHANG ET AL.: "In Vitro Anti-Helicobacter pylori Effects of Medicinal Mushroom Extracts,with Special Emphasis on the Lion’s Mane Mushroom,Hericium erinaceus(Higher Basidiomycetes)", 《INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS》 * |
吴静等: "黄连对幽门螺杆菌的体外抗菌活性研究", 《时珍国医国药》 * |
段玲等: "中药苦豆子体外抗幽门螺杆菌的实验研究", 《中国热带医学》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106309758A (zh) * | 2016-09-30 | 2017-01-11 | 湖南新汇制药股份有限公司 | 一种抗胃肠癌的药物组合物 |
CN107898999A (zh) * | 2017-11-27 | 2018-04-13 | 广东省微生物研究所(广东省微生物分析检测中心) | 一种含有猴头菌蛋白的微生物制剂及其制备方法和用途 |
CN108159085A (zh) * | 2018-01-22 | 2018-06-15 | 梁勇 | 一种益生菌溃疡贴 |
CN110591945A (zh) * | 2019-09-06 | 2019-12-20 | 吉林大学 | 一株用于预防溃疡性结肠炎的优良罗伊氏乳杆菌 |
CN112451540A (zh) * | 2020-11-25 | 2021-03-09 | 华熙生物科技股份有限公司 | 抗幽门螺杆菌消化道内感染活性的透明质酸 |
CN112451540B (zh) * | 2020-11-25 | 2022-03-01 | 华熙生物科技股份有限公司 | 抗幽门螺杆菌消化道内感染活性的透明质酸 |
CN114480231A (zh) * | 2022-04-18 | 2022-05-13 | 南京益瑞兰生物科技有限公司 | 一种抗幽门螺杆菌感染的罗伊氏乳杆菌及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104825570B (zh) | 2019-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104825570A (zh) | 一种抑制幽门螺杆菌的组合物及其用途 | |
KR100988072B1 (ko) | 황칠나무 발효물 및 그것을 포함하는 약학 조성물 | |
CN104382955A (zh) | 一种组合物、用途及保健品 | |
CN111053803B (zh) | 一种具有抗金黄色葡萄球菌作用的组合物及其制备方法与应用 | |
JP2009091277A (ja) | 生薬からなる抗菌性の医薬組成物、抗菌性の医薬製剤 | |
EP2236148B1 (en) | Cgnc for use in treating h. pylori infection | |
CN102133237A (zh) | 一种蜂胶黄酮软胶囊及其制备方法 | |
CN112641097A (zh) | 一种对胃粘膜损伤有辅助保护作用的组合物及应用 | |
CN101711758A (zh) | 芹菜素在制备预防和治疗人缺血损伤引起疾病的药物应用 | |
EP2353604A1 (en) | Pharmaceutical composition and health food comprising rhodiola sachalinensis and oldenlandia diffusa for preventing and treating cancer | |
KR101931556B1 (ko) | 산딸기 미숙과 추출물 및 왕느릅나무의 유백피 추출물의 혼합물을 유효성분으로 포함하는 위장질환 예방 또는 치료용 약학적 조성물 | |
CN107048408A (zh) | 制备具有调理改善癌症病人病症、提高生存质量功效的植物酵素的发酵组合物及制法 | |
KR102572985B1 (ko) | 청각 추출물 및 모과 추출물을 유효성분으로 포함하는 항균용 조성물 | |
KR101082599B1 (ko) | 맛버섯을 이용한 항산화 및 항위암 조성물 및 이를 이용한 기능성 버섯묵 | |
TWI552758B (zh) | 具協同化學治療抗癌藥物的桑黃發酵物及其製備方法與用途 | |
KR100578665B1 (ko) | 위장질환 환자를 위한 생약조성물을 함유하는 건강기능식품 | |
Mazzio et al. | Plants against cancer: the immune-boosting herbal microbiome: not of the plant, but in the plant. Basic concepts, introduction, and future resource for vaccine adjuvant discovery | |
KR20150001334A (ko) | 붉나무 메탄올 추출물을 포함하는 간 섬유화 치료 조성물 및 그 제조 방법 | |
KR101548162B1 (ko) | 황금 추출물, 황련 추출물 및 살리실산을 혼합한 혼합물을 유효성분으로 함유하는 항균용 조성물 | |
KR20120041725A (ko) | 독성이 줄어든 식물 추출물 및 식물 추출물의 독성을 줄이는 방법 | |
KR101188342B1 (ko) | 독성이 줄어든 식물 추출물 및 식물 추출물의 독성을 줄이는 방법 | |
KR20110080184A (ko) | 천련자 추출물을 함유하는 헬리코박터 세균 감염의 예방 및 치료용 약학조성물 및 건강기능식품 | |
CN107296858B (zh) | 一种抗细菌感染药物组合物及其应用 | |
JP3958748B2 (ja) | 抗菌剤 | |
JP2006298853A (ja) | 抗腫瘍性飲食品及び抗腫瘍剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200612 Address after: 514000 1st floor, de'ai street, No.106 Ningxin District, Xingning City, Meizhou City, Guangdong Province Patentee after: Meizhou harmonious Biotechnology Co.,Ltd. Address before: 225001 Department of clinical medicine, School of medicine, Yangzhou University, Huaihailu Road 11, Yangzhou, Jiangsu 1301 Patentee before: Yang Kexi |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 3 / F, 153 Ningxin Dongfeng Road, Xingning City, Meizhou City, Guangdong Province 514000 Patentee after: Meizhou harmonious Biotechnology Co.,Ltd. Address before: 514000 1st floor, de'ai street, Ningxin 106 District, Xingning City, Meizhou City, Guangdong Province Patentee before: Meizhou harmonious Biotechnology Co.,Ltd. |